According to FutureWise analysis the market for bone graft substitutes in 2023 is US$ 3.8 billion, and is expected to reach US$ 6.25 billion by 2031 at a CAGR of 6.40%.
Bone is a flexible organ with remarkable regenerative capabilities. However, for bones to remain healthy, they require osteoblasts, osteoclasts, and osteocytes, along with adequate vascularity, stability, growth hormones, and a proper growth matrix. There are many situations in which one or more of these requirements may not be met, necessitating surgical intervention to promote bone healing. Bone grafting is often used to create an osteoconductive, osteoinductive, and/or osteogenic environment that supports bone healing and repair when additional assistance is needed. Bone defects are becoming an increasingly common clinical issue in orthopedic and trauma surgery. These defects can occur as a result of tumors and bone infections, which typically require surgical removal followed by skeletal repair. Additionally, bone deficiencies frequently arise from fractures due to high-energy trauma or osteoporosis, which also necessitate surgical procedures for bone augmentation. A significant factor contributing to the anticipated rise in bone abnormalities is osteoporotic fractures. To restore bone defects, various options are available, including autografts, allografts, and biomaterial-based bone graft substitutes made from ceramics, synthetic polymers, or natural polymers. While autografts possess osteogenic properties and can be osteoconductive and osteoinductive, they come with challenges, including limited supply, potential donor-site morbidity, and longer recovery times.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Bone Graft Substitutes Market trends that shall affect the overall market growth.
Request a Free Sample @
https://www.futurewiseresearch.com/contact.aspx?rpt=10241&type=requestsample
By Product
- Allografts
- Demineralized Bone Matrix (DBM)
- Synthetic Bone Graft
- Polymer
- Ceramic
- Hydroxyapatite
- Beta TCP
- Xenograft
- Autograft
By Material
- Ceramic-based
- Calcium Phosphate
- Calcium Sulfate
- Polymer-based
- Polylactides
- Polyglycolides
- Polyurethanes
- Others
- Growth Factor-based
- Cell-based
- Others
By Application
- Craniomaxillofacial
- Dental
- Foot And Ankle
- Joint Reconstruction
- Spinal Fusion
- Long Bones
- Others
By End User
- Hospitals
- Clinics
- Ambulatory Care Centers
- Academic And Research Institutes
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Bone Graft Substitutes Market:
- NovaBone Product, LLC.
- Exactech, Inc.
- Medtronic Plc.
- LifeNet Health
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation.
- BioHorizons Implant Systems, Inc.
- Globus Medical, Inc.
- RTI Surgical, Inc
- Geistlich Pharma
- Megagen
- Novadip Biosciences
- Mesoblast Ltd.
- Alphatec Spine, Inc.
- Institut Straumann AG
- NuVasive, Inc.
- OsteoMed LLC
- KYERON Medical Innovations
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=10241&license=multi
**Objectives of this Study: **
- To provide a comprehensive analysis of the Bone Graft Substitutes Market By Product, By Material, By Application, By End User and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
